Antibodies to Optic Nerve Glycosaminoglycans in Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
G1999016
Summary
Although high intraocular pressure (IOP) is frequently associated with glaucoma, some people have the disease without high IOP. In these cases, it has been suggested that nerve death and damage to the optic nerve may result from a person’s own antibodies (autoimmunity) that mistakenly attack the optic nerve and/or its blood supply. Dr. Wax has provided evidence that some glaucoma patients have antibodies that interact with important molecules (called glycosaminoglycans) that help form support structures for the optic nerve. He will now perform a detailed analysis to further characterize the specificity of these antibodies and determine whether there are changes in the glycosaminoglycans of patients with the antibodies. In addition, he will correlate the extent of antibody reactivity to glycosaminoglycans with optic nerve damage. The goal of this study is to confirm the hypothesis that autoimmunity plays a role in glaucoma.
Grants
Related Grants
National Glaucoma Research
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Diana C. Lozano, PhD
Current Organization
Oregon Health & Science University
National Glaucoma Research
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Jennifer Fan Gaskin, MBChB, MD, FRANZCO
Current Organization
Centre for Eye Research Australia (Australia)
National Glaucoma Research
Understanding How Variants in LOXL1 Affect Pseudoexfoliation Glaucoma Risk
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Hannah Youngblood, PhD
Current Organization
Georgia Institute of Technology